Literature DB >> 19286259

The role of the activating receptor NKG2D in autoimmunity.

Tom L Van Belle1, Matthias G von Herrath.   

Abstract

T and NK cell subsets play a crucial role in the immune surveillance designed to fend off dangerous pathogens while leaving endogenous cells untouched. However, occasionally T cells do initiate an attack against self and are therefore termed autoreactive. Moreover, both NK and T cells can be stimulated by danger signals released by cells under "stress", i.e. infection, ongoing necrotic cell death, etc. Consequently, the inappropriate triggering of danger signals, or a failure to switch these off once the immune response has been resolved, can have serious consequences for the host. Ligands for the activating receptor NKG2D (natural killer group 2 member D) are such key danger signals that are presented by "stressed" cells. In this review, we discuss the current knowledge on NKG2D and its ligands in the context of autoimmune diseases and immune-mediated diseases that inadvertently target endogenous cells and/or tissue.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19286259     DOI: 10.1016/j.molimm.2009.02.023

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  27 in total

1.  Systematic mutation and thermodynamic analysis of central tyrosine pairs in polyspecific NKG2D receptor interactions.

Authors:  David J Culpepper; Michael K Maddox; Andrew B Caldwell; Benjamin J McFarland
Journal:  Mol Immunol       Date:  2010-11-12       Impact factor: 4.407

2.  EphA2 targeting peptide tethered bioreducible poly(cystamine bisacrylamide-diamino hexane) for the delivery of therapeutic pCMV-RAE-1γ to pancreatic islets.

Authors:  Katherine S Blevins; Ji Hoon Jeong; Mei Ou; Jonathan H Brumbach; Sung Wan Kim
Journal:  J Control Release       Date:  2011-10-28       Impact factor: 9.776

3.  Changes in natural killer cell subsets in pediatric liver transplant recipients.

Authors:  Betty Pham; Karine Piard-Ruster; Richard Silva; Amy Gallo; Carlos O Esquivel; Olivia M Martinez; Sheri M Krams
Journal:  Pediatr Transplant       Date:  2012-03

4.  NKG2D signaling on CD8⁺ T cells represses T-bet and rescues CD4-unhelped CD8⁺ T cell memory recall but not effector responses.

Authors:  Andrew Zloza; Frederick J Kohlhapp; Gretchen E Lyons; Jason M Schenkel; Tamson V Moore; Andrew T Lacek; Jeremy A O'Sullivan; Vineeth Varanasi; Jesse W Williams; Michael C Jagoda; Emily C Bellavance; Amanda L Marzo; Paul G Thomas; Biljana Zafirova; Bojan Polić; Lena Al-Harthi; Anne I Sperling; José A Guevara-Patiño
Journal:  Nat Med       Date:  2012-02-26       Impact factor: 53.440

Review 5.  MICA SNPs and the NKG2D system in virus-induced HCC.

Authors:  Kaku Goto; Naoya Kato
Journal:  J Gastroenterol       Date:  2014-10-01       Impact factor: 7.527

Review 6.  Immune aging and autoimmunity.

Authors:  Jörg J Goronzy; Cornelia M Weyand
Journal:  Cell Mol Life Sci       Date:  2012-04-01       Impact factor: 9.261

Review 7.  Insights into NK cell biology from human genetics and disease associations.

Authors:  Stephanie M Wood; Hans-Gustaf Ljunggren; Yenan T Bryceson
Journal:  Cell Mol Life Sci       Date:  2011-08-27       Impact factor: 9.261

8.  Human microRNA-1245 down-regulates the NKG2D receptor in natural killer cells and impairs NKG2D-mediated functions.

Authors:  J Luis Espinoza; Akiyoshi Takami; Katsuji Yoshioka; Katsuya Nakata; Tokiharu Sato; Yoshihito Kasahara; Shinji Nakao
Journal:  Haematologica       Date:  2012-04-04       Impact factor: 9.941

9.  Innate immune recognition of double-stranded RNA triggers increased expression of NKG2D ligands after virus infection.

Authors:  Gloria Esteso; Susana Guerra; Mar Valés-Gómez; Hugh T Reyburn
Journal:  J Biol Chem       Date:  2017-10-06       Impact factor: 5.157

Review 10.  DNA Damage Response in the Adaptive Arm of the Immune System: Implications for Autoimmunity.

Authors:  Theodora Manolakou; Panayotis Verginis; Dimitrios T Boumpas
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.